SCHEMBL7989971

SCHEMBL7989971

CCOC1CCC(CS)(C(=O)N[C@@H](Cc2ccccc2)C(=O)NC2CCCC2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 19/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989969 1.00 MMP1 (1.00) MMP1
SCHEMBL7981453 0.99 MMP1 (1.00) MMP1
SCHEMBL7981458 0.99 MMP1 (1.00) MMP1
SCHEMBL7985544 0.90 MMP1 (1.00) MMP1
SCHEMBL7064472 0.89 MMP1 (1.00) MMP1
SCHEMBL7064613 0.89 MMP1 (1.00) MMP1
SCHEMBL8166286 0.88 MMP1 (1.00) MMP1
SCHEMBL8166290 0.88 MMP1 (1.00) MMP1
SCHEMBL7370872 0.87 MMP1 (0.83) MMP1
SCHEMBL7370871 0.87 MMP1 (0.83) MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201133-B1 FOR INHIBITING MATRIX-DEGRADING METALLOPROTEINASES IN MAMMALS, TREATING TNF ALPHA AND MATRIX METALLOPROTEINASE DEPENDENT DISEASES OR CONDITIONS, CANCER NOVARTIS AG (CH) 2001-03-13 US disclosed
US-6034136-A METALLOPROTEINASE INHIBITOR NOVARTIS AG (CH) 2000-03-07 US disclosed